SEARCH

SEARCH BY CITATION

References

  • 1
    Tenover FC, Crawford JT, Huebner RE, Geiter LJ, Horsburgh Jr, GoodRC. The resurgence of tuberculosis: is your laboratory ready? J Clin Microbiol 1993; 31(4): 767 70.
  • 2
    Roberts GD, Goodman NL, Heifets L et al. Evaluation of the BACTEC radiometric method for the recovery of mycobacteria and drug susceptibility testing of M. tuberculosis from acid-fast smear-positive specimens. J Clin Microbiol 1983; 18(3): 689 96.
  • 3
    Palaci M, Mizuka Ueki SY, Nakamura Sato D, Da Silva Telles MA, Curcio M, Matheus Silva EA. Evaluation of Mycobacteria Growth Indicator Tube for the recovery and drug susceptibility testing of M. tuberculosis isolates from respiratory specimens. J Clin Microbiol 1996; 34(3): 762 4.
  • 4
    Walters SB & Hanna BA. Testing of susceptibility of M. tuberculosis to isoniazid and rifampin by Mycobacteria Growth Indicator Tube method. J Clin Microbiol 1996; 31(6): 1565 7.
  • 5
    Bergman JS & Wood GL. Reliability of Mycobacteria Growth Indicator Tube for testing susceptibility of M. tuberculosis to ethambutol and streptomycin. J Clin Microbiol 1997; 35(12): 3325 7.
  • 6
    Bergman JS & Wood GL. Mycobacteria Growth Indicator Tube for susceptibility testing of M. tuberculosis to isoniazid and rifampicin. Diagn Microbiol Infect Dis 1997; 27: 153 6.
  • 7
    Reisner BS, Gaston AM, Woods GL. Evaluation of Mycobacteria Growth Indicator Tube for susceptibility testing of M. tuberculosis to isoniazid and rifampin. Diagn Microbiol Infect Dis 1995; 22: 325 9.DOI: 10.1016/0732-8893(95)00147-7
  • 8
    Kent PT & Kubica GP. Public health mycobacteriology. A guide for level III laboratory. Atlanta, Georgia: Centers for Disease Control, 1985.
  • 9
    Nolte FS & Metchok B. Mycobacterium. In: MurrayPR, BaronEJ, PflallerMA, TenoverFC, YolkenRH, eds. Manual of clinical microbiology, 6th edn. Washington DC: ASM Press, 1995: 400 37.
  • 10
    Rastogi N, Goh KS, David HL. Drug susceptibility testing in tuberculosis: a comparison of the proportion methods using Lowenstein–Jensen, Middlebrook 7H10 and 7H11 agar media and radiometric method. Res Microbiol 1989; 140: 405 17.
  • 11
    David H, Levy-Frebault V, Thorel M. Méthodes de La boratoire pour Mycobactériologie Clinique. Paris: Commission des laboratoires de référence et d'Expertise de l'Institut Pasteur, 1989.
  • 12
    Lazlo A, Rohman M, Raviglione M, Buestro F. Quality assurance programme for drug susceptibility testing of M. tuberculosis in the WHO/IUATLD supranational laboratory network: first round of proficiency testing . Int J Tuberc Lung Dis 1997; 1(3): 231 8.
  • 13
    Cambeau E, Wichalcz C, Ouiller G, Truffot-Pernot C, Boulahbal F, Grosset J. Evaluation du nouveau test de sensibilité aux antituberculeux MGIT AST. In: Résumés des communications des 5ème Journées de Mycobactériologie de Langue Française, Nice. Nice, 1996: 266 pp.
  • 14
    Welscher HM, Kissling P, Pfyffer GE. Susceptibility testing of. M. tuberculosis using Mycobacteria Growth Indicator Tube (MGIT AST SIRE System) [abstract P1082]. In: Abstracts of the 8th ECCMID, Lausanne. Lausanne, 1997: 266.
  • 15
    Hanna BA, Rexer CH, Walters SB. Evaluation of BBL MGIT™ AST SIRE System for susceptibility testing of M. tuberculosis[abstract D-105]. In: Abstracts of the 38th ICAAC, San Diego. San Diego, 1998: 266 pp.
  • 16
    Van Eldere J, Moons V, Standaert K, Verbist L. Evaluation of the Mycobacteria Growth Indicator Tube for drug susceptibility testing of M. tuberculosis[abstract P1083.266]. In: Abstracts of the 8th ECCMID, Lausanne. Lausanne, 1997.
  • 17
    Gerome P, Fabre M, Soler C, Cavallo JD, Vagueresse R. Comparison of Mycobacteria Growth Indicator Tube method and method of proportion for drug susceptibility of M. tuberculosis[abstract D-92] . In: Abstracts of the 38th ICAAC, San Diego. San Diego, 266 pp. 1998.